CEO SUMMARY: Both the pending VALID Act and SALSA Act continue to push ahead as 2022 comes to an end. Meanwhile, a new bill centered on the Physician Fee Schedule may protect pathologist payments. These three different proposals share something in common: To pass this year, they need to be part of a larger spending […]
VALID and SALSA Acts Still Pending in Congress
Race is on to address lab test pricing cuts, regulation of LDTs, and physician fee changes
- By Scott Wallask
- > From the Volume XXIX, No. 16 - November 21, 2022 Issue
- Tags: cap, clfs, clia, Clinical Laboratory Fee Schedule, Clinical Laboratory Improvement Amendments of 1988, College of American Pathologists, CRD Associates, Erin Will Morton, FDA, H.R.8800, lab risk & compliance, laboratory-developed test, ldt, Medicare Part B, national independent laboratory association, NILA, PAMA, Physician Fee Schedule, Protecting Access to Medicare Act of 2014, S.2209, S.4449, SALSA, Saving Access to Laboratory Services Act, Supporting Medicare Providers Act, U.S. Food and Drug Administration, VALID, Verifying Accurate Leading-edge IVCT Development Act
